<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Publicover J</submitter><funding>Intramural NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NIAID NIH HHS</funding><pagination>1154-62</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3049376</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>121(3)</volume><pubmed_abstract>HBV is a noncytopathic hepadnavirus and major human pathogen that causes immune-mediated acute and chronic hepatitis. The immune response to HBV antigens is age dependent: viral clearance occurs in most adults, while neonates and children usually develop chronic infection and liver disease. Here, we characterize an animal model for HBV infection that recapitulates the key differences in viral clearance between early life and adulthood and find that IL-21 may be part of an effective primary hepatic immune response to HBV. In our model, adult mice showed higher HBV-dependent IL-21 production in liver, compared with that of young mice. Conversely, absence of the IL-21 receptor in adult mice resulted in antigen persistence akin to that of young mice. In humans, levels of IL-21 transcripts were</pubmed_abstract><journal>The Journal of clinical investigation</journal><pubmed_title>IL-21 is pivotal in determining age-dependent  effectiveness of immune responses  in a mouse model of human hepatitis B.</pubmed_title><pmcid>PMC3049376</pmcid><funding_grant_id>P30 DK026743</funding_grant_id><funding_grant_id>T32DK060414</funding_grant_id><funding_grant_id>P30DK026743</funding_grant_id><funding_grant_id>T32 DK060414</funding_grant_id><funding_grant_id>R01AI068090</funding_grant_id><funding_grant_id>R01 AI068090</funding_grant_id><pubmed_authors>Spolski R</pubmed_authors><pubmed_authors>Baron JL</pubmed_authors><pubmed_authors>Publicover J</pubmed_authors><pubmed_authors>Avanesyan L</pubmed_authors><pubmed_authors>Nishimura S</pubmed_authors><pubmed_authors>Wang ZE</pubmed_authors><pubmed_authors>Goodsell A</pubmed_authors><pubmed_authors>Cooper S</pubmed_authors><pubmed_authors>Vilarinho S</pubmed_authors><pubmed_authors>Leonard WJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>IL-21 is pivotal in determining age-dependent  effectiveness of immune responses  in a mouse model of human hepatitis B.</name><description>HBV is a noncytopathic hepadnavirus and major human pathogen that causes immune-mediated acute and chronic hepatitis. The immune response to HBV antigens is age dependent: viral clearance occurs in most adults, while neonates and children usually develop chronic infection and liver disease. Here, we characterize an animal model for HBV infection that recapitulates the key differences in viral clearance between early life and adulthood and find that IL-21 may be part of an effective primary hepatic immune response to HBV. In our model, adult mice showed higher HBV-dependent IL-21 production in liver, compared with that of young mice. Conversely, absence of the IL-21 receptor in adult mice resulted in antigen persistence akin to that of young mice. In humans, levels of IL-21 transcripts were</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Mar</publication><modification>2025-04-07T00:14:23.295Z</modification><creation>2019-03-27T00:39:24Z</creation></dates><accession>S-EPMC3049376</accession><cross_references><pubmed>21393863</pubmed><doi>10.1172/jci44198</doi><doi>10.1172/JCI44198</doi></cross_references></HashMap>